TY - JOUR
T1 - Statistical methods for cohort studies of CKD
T2 - Survival analysis in the setting of competing risks
AU - Chronic Renal Insufficiency Cohort (CRIC) Study Investigators
AU - Hsu, Jesse Yenchih
AU - Roy, Jason A.
AU - Xie, Dawei
AU - Yang, Wei
AU - Shou, Haochang
AU - Anderson, Amanda Hyre
AU - Landis, J. Richard
AU - Jepson, Christopher
AU - Wolf, Myles
AU - Isakova, Tamara
AU - Rahman, Mahboob
AU - Feldman, Harold I.
N1 - Publisher Copyright:
© 2017 by the American Society of Nephrology.
PY - 2017/7/7
Y1 - 2017/7/7
N2 - Survival analysis is commonly used to evaluate factors associated with time to an event of interest (e.g., ESRD, cardiovascular disease, and mortality) among CKD populations. Time to the event of interest is typically observed only for some participants. Other participants have their event time censored because of the end of the study, death, withdrawal from the study, or some other competing event. Classic survival analysis methods, such as Cox proportional hazards regression, rely on the assumption that any censoring is independent of the event of interest. However, in most clinical settings, such as in CKD populations, this assumption is unlikely to be true. For example, participants whose follow-up time is censored because of health-related death likely would have had a shorter time to ESRD, had they not died. These types of competing events that cause dependent censoring are referred to as competing risks. Here, we first describe common circumstances in clinical renal research where competing risks operate and then review statistical approaches for dealing with competing risks. We compare two of the most popular analytical methods used in settings of competing risks: cause-specific hazards models and the Fine and Gray approach (subdistribution hazards models). We also discuss practical recommendations for analysis and interpretation of survival data that incorporate competing risks. To demonstrate each of the analytical tools, we use a study of fibroblast growth factor 23 and risks of mortality and ESRD in participants with CKD from the Chronic Renal Insufficiency Cohort Study.
AB - Survival analysis is commonly used to evaluate factors associated with time to an event of interest (e.g., ESRD, cardiovascular disease, and mortality) among CKD populations. Time to the event of interest is typically observed only for some participants. Other participants have their event time censored because of the end of the study, death, withdrawal from the study, or some other competing event. Classic survival analysis methods, such as Cox proportional hazards regression, rely on the assumption that any censoring is independent of the event of interest. However, in most clinical settings, such as in CKD populations, this assumption is unlikely to be true. For example, participants whose follow-up time is censored because of health-related death likely would have had a shorter time to ESRD, had they not died. These types of competing events that cause dependent censoring are referred to as competing risks. Here, we first describe common circumstances in clinical renal research where competing risks operate and then review statistical approaches for dealing with competing risks. We compare two of the most popular analytical methods used in settings of competing risks: cause-specific hazards models and the Fine and Gray approach (subdistribution hazards models). We also discuss practical recommendations for analysis and interpretation of survival data that incorporate competing risks. To demonstrate each of the analytical tools, we use a study of fibroblast growth factor 23 and risks of mortality and ESRD in participants with CKD from the Chronic Renal Insufficiency Cohort Study.
KW - Analysis
KW - Cardiovascular diseases
KW - Cause-specific
KW - Chronic
KW - Cox proportional hazards models
KW - Cumulative incidence function
KW - FGF-23
KW - Fibroblast growth factor 23
KW - Fibroblast growth factors
KW - Follow-up studies
KW - Kidney failure
KW - Proportional hazards models
KW - Renal insufficiency
KW - Risk
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=85021889692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021889692&partnerID=8YFLogxK
U2 - 10.2215/CJN.10301016
DO - 10.2215/CJN.10301016
M3 - Article
C2 - 28242844
AN - SCOPUS:85021889692
SN - 1555-9041
VL - 12
SP - 1181
EP - 1189
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 7
ER -